Oncotarget

Meta-Analysis:

ABO blood group and ovarian reserve: a meta-analysis and systematic review

Jie Deng, Mengmeng Jia, Xiaolin Cheng, Zhen Yan, Dongmei Fan and Xiaoyu Tian _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:25628-25636. https://doi.org/10.18632/oncotarget.15759

Metrics: PDF 2567 views  |   HTML 2170 views  |   ?  


Abstract

Jie Deng1, Mengmeng Jia1, Xiaolin Cheng1, Zhen Yan1, Dongmei Fan1 and Xiaoyu Tian1

1 Department of Obstetrics and Gynecology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China

Correspondence to:

Xiaoyu Tian, email:

Keywords: ABO blood group, ovarian reserve, systematic review, meta-analysis

Received: November 30, 2016 Accepted: February 10, 2017 Published: February 27, 2017

Abstract

Ovarian reserve reflects a woman's fertility potential. The ABO blood group system is a very stable genetic marker. Although many recent studies have explored the relationship between ABO blood group and ovarian reserve, a consensus has not yet been reached. This paper is the first meta-analysis and systematic review of the relationship between ABO blood type and ovarian reserve. We analyzed seven cross-sectional studies evaluating follicle stimulating hormone (FSH) or anti-Mullerian hormone (AMH) levels in 55,113 participants to determine ovarian reserve. This study found no relationship between ABO blood type and ovarian reserve when FSH was used as an indicator of ovarian reserve (A vs non-A:OR=1.03, 95% CI:0.96-1.11; B vs non-B: OR=0.98, 95% CI:0.75-1.29; AB vs non-AB:OR=0.96, 95% CI:0.71-1.30; O vs non-O:OR=1.03, 95%CI:0.74-1.43).There was also no relationship between ABO blood type and ovarian reserve when AMH was used as an indicator (A vs non-A:OR=0.89, 95% CI:0.76-1.03; B vs non-B:OR=1.02, 95% CI:0.80-1.30; AB vs non-AB:OR=1.14, 95% CI:0.80-1.64, O vs non-O:OR=1.07, 95% CI:0.86-1.34). Overall, the current study found no relationship between ABO blood group and ovarian reserve. However, additional rigorous, high-quality and multi-indicator studies with large sample sizes are required for further verification.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15759